AMOTL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.860600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.242600E-01
Normal-vs-Stage2
2.967400E-01
Normal-vs-Stage3
1.244230E-01
Normal-vs-Stage4
5.393200E-01
Stage1-vs-Stage2
6.206200E-01
Stage1-vs-Stage3
4.480400E-01
Stage1-vs-Stage4
9.662000E-01
Stage2-vs-Stage3
5.633600E-01
Stage2-vs-Stage4
7.254000E-01
Stage3-vs-Stage4
3.514200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.480600E-01
Normal-vs-AfricanAmerican
7.380800E-01
Normal-vs-Asian
4.001800E-01
Caucasian-vs-AfricanAmerican
3.199600E-01
Caucasian-vs-Asian
7.819800E-01
AfricanAmerican-vs-Asian
4.455000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.072400E-01
Normal-vs-Female
2.762600E-01
Male-vs-Female
7.266400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.576400E-01
Normal-vs-Age(41-60Yrs)
4.912200E-01
Normal-vs-Age(61-80Yrs)
2.647600E-01
Normal-vs-Age(81-100Yrs)
1.560500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.301600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.985800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.748000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.530400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.164490E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.084400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.240400E-01
Normal-vs-Daily Drinker
1.316930E-03
Normal-vs-Weekly Drinker
5.421000E-01
Normal-vs-Occasional Drinker
2.524000E-01
Normal-vs-Social Drinker
8.987000E-01
Non Drinker-vs-Daily Drinker
1.781400E-01
Non Drinker-vs-Weekly Drinker
2.494800E-01
Non Drinker-vs-Occasional Drinker
4.733800E-01
Non Drinker-vs-Social Drinker
1.175180E-01
Daily Drinker-vs-Weekly Drinker
7.842300E-02
Daily Drinker-vs-Occasional Drinker
6.202400E-02
Daily Drinker-vs-Social Drinker
3.334100E-02
Weekly Drinker-vs-Occasional Drinker
6.166800E-01
Weekly Drinker-vs-Social Drinker
5.198600E-01
Occasional Drinker-vs-Social Drinker
2.600600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.111800E-01
Normal-vs-Grade 2
3.342400E-01
Normal-vs-Grade 3
3.581600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.886400E-01
Grade 1-vs-Grade 3
6.507400E-01
Grade 1-vs-Grade 4
5.111800E-01
Grade 2-vs-Grade 3
9.869800E-01
Grade 2-vs-Grade 4
3.342400E-01
Grade 3-vs-Grade 4
3.581600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.846000E-01
Normal-vs-NonDiabetic
2.060600E-01
Diabetic-vs-NonDiabetic
6.307000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.226200E-01
Normal-vs-NoPancreatitis
1.992020E-01
Pancreatitis-vs-NoPancreatitis
6.325600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.637400E-01
Normal-vs-N1
2.706600E-01
N0-vs-N1
8.071000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.074800E-01
Normal-vs-TP53-NonMutant
3.473600E-01
TP53-Mutant-vs-TP53-NonMutant
4.580800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
